Lv1
40 积分 2025-03-19 加入
Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial
5小时前
求助中
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single‐center, single‐arm, phase 2 trial
30天前
已完结
Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis
1个月前
已完结
老年急性髓系白血病的治疗
1个月前
已完结
Venetoclax Has Potent Efficacy in NPM1 mutated AML with Acquired Resistance Associated with Either Perturbed Pro-Survival Signalling or NPM1 wild-Type Populations
1个月前
已关闭
Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis
2个月前
已完结
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia
2个月前
已完结
The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia
3个月前
已完结
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015
3个月前
已完结
皖公网安备34019202002308
